Quetmolimab: A Deep Dive into KANAb 001 and E-6011 Quest molecule, E-6011, is a new treatment aimed at programmed cell death protein 1. Initial clinical findings from both programs, KANAb 001 and E-6011, suggest https://www.targetmol.com/compound/quetmolimab